ArticleCardiology and therapy2023

Idarucizumab for Emergency Reversal of the Anticoagulant Effects of Dabigatran: Final Results of a Japanese Postmarketing Surveillance Study.

Masahiro Yasaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.